Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Purpose. To compare the outcomes of trabeculectomy using two different routes of bevacizumab administration as an adjunct in patients with primary open angle glaucoma. Methods. Prospective, randomized, masked trial that included 180 eyes of 180 patients of documented primary open angle glaucoma were...
Saved in:
| Main Authors: | Alper Bilgic, Aditya Sudhalkar, Anand Sudhalkar, Megha Trivedi, Viraj Vasavada, Shail Vasavada, Vaishali Vasavada, Samaresh Srivastava |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2020/8359398 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal Bevacizumab as Adjunctive Therapy for Bleb Survival in Trabeculectomy in Rabbit Eyes
by: Margarita Echavez, MD, et al.
Published: (2012-06-01) -
Topical Bevacizumab as Adjunctive Therapy for Bleb Survival after Trabeculectomy in the Rabbit Model
by: Jaime Rafeal Hubilla Tripon, MD, et al.
Published: (2012-12-01) -
Pre-trabeculectomy intravitreal injections of Bevacizumab for treating neovascular glaucoma in diabetic patients
by: Marjanović Ivan, et al.
Published: (2020-01-01) -
Harnessing beta-cell replication: advancing molecular insights to regenerative therapies in diabetes
by: Rupangi C. Vasavada, et al.
Published: (2025-06-01) -
Microtrabeculectomy versus Conventional Trabeculectomy in Primary Open Angle Glaucoma: A Prospective Interventional Study
by: Rekha Ramesh Mudhol, et al.
Published: (2025-01-01)